Otoferlin Activators are a diverse group of chemical compounds that indirectly enhance the functional activity of Otoferlin, primarily involved in synaptic vesicle exocytosis and neurotransmitter release. Forskolin, by increasing intracellular cAMP levels, activates PKA, leading to the phosphorylation of proteins crucial in vesicle fusion, indirectly facilitating Otoferlin's function in neurotransmitter release. BAPTA-AM, as a calcium chelator, finely tunes the intracellular calcium levels, vital for Otoferlin's role in synaptic vesicle docking and fusion. Phorbol 12-myristate 13-acetate (PMA) and Niflumic acid, through PKC activation and chloride channel blocking respectively, contribute to the regulation of synaptic activity, thereby indirectly enhancing Otoferlin's involvement in vesicle dynamics. Tetrodotoxin's role in blocking voltage-gated sodium channels helps to modulate neuronal excitability, further delineating Otoferlin's role in synaptic processes. Ryanodine and Dantrolene, by interacting with ryanodine receptors, influence calcium-mediated neurotransmitter release, a critical aspect of Otoferlin's function.
In addition to these, other compounds like Thapsigargin, Omega-conotoxin GVIA, Gabazine, NBQX, and Methyllycaconitine also play significant roles in modulating synaptic activity, thereby indirectly influencing Otoferlin's function. Thapsigargin, by inhibiting the SERCA pumps, alters calcium dynamics, crucial for synaptic vesicle fusion where Otoferlin is essential. Omega-conotoxin GVIA's inhibition of N-type calcium channels affects calcium influx, integral to Otoferlin-mediated vesicle exocytosis. Gabazine, by antagonizing GABA_A receptors, and NBQX, as an AMPA receptor antagonist, regulate inhibitory and excitatory neurotransmission, respectively, impacting synaptic activity and vesicle release processes involving Otoferlin. Methyllycaconitine's antagonism of nicotinic acetylcholine receptors further influences synaptic transmission, affecting vesicle fusion processes that Otoferlin facilitates. Collectively, these Otoferlin Activators, through their targeted effects on synaptic signaling and vesicle dynamics, play a crucial role in enhancing the functionality of Otoferlin without the need for upregulating its expression or direct activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by raising cAMP levels, indirectly enhances Otoferlin's function in synaptic vesicle exocytosis. The elevated cAMP activates PKA, which can phosphorylate proteins involved in vesicle fusion, thereby facilitating Otoferlin’s role in neurotransmitter release. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM, a calcium chelator, indirectly promotes Otoferlin activity by modulating intracellular calcium levels. This regulation of calcium is crucial for synaptic vesicle docking and fusion, processes in which Otoferlin is directly involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, as a PKC activator, indirectly enhances Otoferlin's function by promoting phosphorylation of proteins involved in synaptic vesicle release, a process where Otoferlin is a key player. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid, as a chloride channel blocker, indirectly enhances Otoferlin's role by influencing ionic balances crucial for synaptic vesicle release, a process where Otoferlin is essential. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine, by modulating ryanodine receptors, indirectly influences Otoferlin’s role in calcium-mediated neurotransmitter release at synapses. This modulation is vital for the proper functioning of Otoferlin in vesicle dynamics. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin, by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), indirectly enhances Otoferlin's role in calcium-dependent exocytosis by altering calcium dynamics critical for synaptic vesicle fusion. | ||||||
Gabazine | 105538-73-6 | sc-211552 | 10 mg | $714.00 | 3 | |
Gabazine, a GABA_A receptor antagonist, indirectly enhances Otoferlin’s function by modulating inhibitory neurotransmission, thereby affecting the synaptic activity where Otoferlin is crucial for neurotransmitter release. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene, by inhibiting ryanodine receptors, indirectly influences Otoferlin’s role in synaptic vesicle exocytosis by modulating calcium release, critical for the neurotransmitter release process. | ||||||